RCA’s Research Institute is making strides in clinical trials.
Dr. Mark Barakat discusses how clinical trials are helping patients maintain their vision.
Dr. Mark Barakat discusses how clinical trials are helping patients maintain their vision.
Watch Dr. Mark Barakat discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD.
Watch Dr. Mark R. Barakat sit down with CBS to talk about being the first in AZ to administer gene therapy to treat Age-related Macular Degeneration.
Watch Dr. Mark R. Barakat discuss the results of the Kingfisher trail, a study employing broluizumab for the treatment of diabetic macular edema with Retina Synthesis.